Fenwick securities enforcement co-chair Michael Dicke spoke with CNN, discussing best practices for disclosing when a company’s CEO is experiencing a serious health issue.
Dicke recommended that boards have any public statements about the medical condition and its treatment verified as accurate by a medical professional.
“It could be the doctors involved in treating the executive or it could be an outside resource who is medically qualified to evaluate the statement,” he told CNN.
The full article is available on the CNN website. For more guidance on how and when to disclose an executive’s serious health condition, see this article that Dicke co-authored with Susan Muck, David Bell and Alison Jordan, which was also featured by CNN.